Get 20% lifetime commission for referring investors to digrin.com
here.
Aarti Pharmalabs Limited (AARTIPHARM.NS) Financials
AARTIPHARM.NS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 23.1 billion | 6.6 billion |
2023-06-30 | ? | ? |
2023-03-31 | 22.3 billion | 6.7 billion |
AARTIPHARM.NS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 375.4 million | ? |
2023-09-30 | 362.8 million | ? |
2023-06-30 | 344.0 million | ? |
2023-03-31 | 702.4 million | ? |
AARTIPHARM.NS Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 527.6 million |
2023-09-30 | 518.0 million |
2023-06-30 | 470.9 million |
2023-03-31 | 588.4 million |
AARTIPHARM.NS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | 1.2 billion | - | - |
2023-06-30 | - | - | - |
2023-03-31 | 989.9 million | - | 5.3 million |
AARTIPHARM.NS Shares Outstanding
AARTIPHARM.NS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | - | - | - | - |
2023-06-30 | - | - | - | - |
2023-03-31 | 331.5 million | - | 18.4 million | 143.0 million |
AARTIPHARM.NS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 4.5 billion | 2.4 billion |
2023-09-30 | 4.4 billion | 2.5 billion |
2023-06-30 | 4.6 billion | 2.7 billion |
2023-03-31 | 4.9 billion | 1.2 billion |
AARTIPHARM.NS
Price: ₹614
52 week price:
Earnings Per Share: 21.46 INR
P/E Ratio: 23.09
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 41.0 billion